This article describes a new, combined, quantitative method for assessing excipient risks that has been developed by the authors as one possible risk evaluation method.
Tetiana Kolisnyk
Advertisement
Articles by Tetiana Kolisnyk
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
3
USP Reports Drug Discontinuations on the Rise
4
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
5